| No images? Click here  13 August 2024 SITUATION REPORT COVID-19 epidemiological update – 13 August 2024OverviewSARS-CoV-2 PCR percent positivity during the four-week reporting period from 24 June to 21 July 2024, as detected in integrated sentinel surveillance as part of the Global Influenza Surveillance and Response System (GISRS) and reported to FluNet increased from 7.4% in the beginning week of the reporting period to 13.0% in the last across eighty-five countries. During this period, an average of 17 358 specimens across 85 countries were tested for SARS-CoV-2 each week. Globally, JN.1 is the most reported variant of interest (VOI), now reported by 135 countries, accounting for 25.7% of sequences in week 29, having declined from a prevalence of 30.2% in week 26. KP.3.1.1 and LB.1, both descendant lineages of JN.1 and variants under monitoring (VUMs), showed an increasing prevalence globally. They accounted for 18.6% and 9.3% of sequences in week 29 (week ending on 21 July 2024) compared to 9.4% and 7.6% in week 26, respectively. KP.3, KP.2, JN.1.7, and JN.1.18 (all VUMs) are declining. KP.3 accounted for 29.4% of sequences in week 29 compared to 32.8% in week 26 while KP.2 declined to 12.8% in week 29 from 15.3% reported in week 26. Globally, during the 28-day period (24 June to 21 July 2024), the number of new cases and deaths increase by 30% and 26% compared to the previous 28-day period (27 May to 23 June 2024), with over one hundred and eighty-six thousand new cases reported across 96 (41%) countries and more than two thousand eight hundred new fatalities reported across 35 (15%) countries, respectively. As of 21 July 2024, over 775 million confirmed cases and more than seven million deaths have been reported globally since the beginning of pandemic. During the same period, 46 and 35 countries provided data at least once on COVID-19 hospitalizations and admissions to an intensive care unit (ICU), respectively. From the available data, over 23 000 new hospitalizations and more than 600 new ICU admissions were reported. Among the countries reporting these data consistently over the current and past reporting period, there was an overall increase of 11% and 3% in new hospitalizations and new ICU admissions, respectively. WHO published the latest COVID-19 Vaccination Insights Report for quarter one (Jan.-Mar.) 2024. Globally, 9.8 million individuals received a dose of COVID-19 vaccine across 73 reporting Member States (MS). containing 22% of the global population. Among older adults, 4.9 million individuals received a dose across the 60 MS reporting on uptake in this group, corresponding to an uptake rate of 0.42% so far this year. In this edition, we include:
 Media contacts:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
0 Comments